Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 114,694 | 37,457 | 68,387 | 27,748 | -27,943 |
| Depreciation Amortization | 2,064 | 1,472 | 24,839 | 19,763 | 14,759 |
| Income taxes - deferred | 4,577 | 3,623 | -21,909 | N/A | N/A |
| Accounts receivable | 13,350 | 12,876 | 4,711 | 17,201 | 17,200 |
| Accounts payable and accrued liabilities | -1,717 | -2,431 | -7,176 | -5,415 | -7,030 |
| Other Working Capital | -11,080 | -9,771 | -19,248 | 15,084 | -7,226 |
| Other Operating Activity | -18,515 | -15,513 | 30,545 | 17,465 | 17,754 |
| Operating Cash Flow | $103,373 | $27,713 | $80,149 | $91,846 | $7,514 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 70,778 | 57,774 |
| PPE Investments | -39 | -33 | 506,232 | 233,655 | 234,126 |
| Purchase Of Investment | -3,269 | N/A | -15,000 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 70,778 | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | 272,945 | 272,945 |
| Other Investing Activity | 3,469 | 0 | 24,805 | 297,950 | 282,945 |
| Investing Cash Flow | $161 | $-33 | $586,815 | $602,383 | $574,845 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -53,462 | N/A | -667 | N/A | N/A |
| Common Stock Issued | 256 | 256 | 15,390 | 15,413 | 15,631 |
| Dividend Paid | -59,679 | N/A | -912,580 | -506,612 | -506,382 |
| Other Financing Activity | 54,726 | 17,729 | 19,317 | 11,647 | 29,367 |
| Financing Cash Flow | $-58,159 | $17,985 | $-878,540 | $-479,552 | $-461,384 |
| Beginning Cash Position | 129,058 | 129,058 | 340,634 | 340,634 | 340,634 |
| End Cash Position | 174,433 | 174,723 | 129,058 | 555,311 | 461,609 |
| Net Cash Flow | $45,375 | $45,665 | $-211,576 | $214,677 | $120,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103,373 | 27,713 | 80,149 | 91,846 | 7,514 |
| Capital Expenditure | -39 | -33 | -3,273 | -2,905 | -2,434 |
| Free Cash Flow | 103,334 | 27,680 | 76,876 | 88,941 | 5,080 |